Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-322-3 | CAS number: 937-14-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The substance was negative in a reliable Ames test (bacterial reverse mutation assay) employing Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100, and Escherichia coli strain WP2 uvrA, both in the presence and absence of a metabolic activation system (rat liver S9).
The substance was negative in a reliable chromosome aberration test employing cultured human lymphocytes, either in the presence or absence of a metabolic activation system (rat liver S9).
The substance was negative in a reliable TK mutation assay, both in the presence and absence of a metabolic activation system.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 November 2017 - 14 December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- An incorrect amount of the positive control was added to the plates. Since all positive control values were within the laboratory historical control data ranges, this deviation has no influence on the results of the study.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: A0378021
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: In refrigerator (2-8°C)
- Stability under test conditions: 31 October 2019 (retest date)
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was soluble in ethanol. - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes (S9 homogenate) from animals treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- Dose-range finding test - eight concentrations, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate were tested in triplicate. The highest concentration of the test item used in the first mutation assay was the level at which the test item inhibited bacterial growth.
First Experiment: Direct Plate Assay - 0.18, 0.55, 1.7, 5.4, 17 and 52 μg/plate
Second Experiment: Pre-Incubation Assay - 0.17, 0.55, 1.7, 5.4, 17, 52 and 164 µg/plate using TA100 and WP2uvrA. Based on the results of this test the following concentrations were used for TA1535, TA1537 and TA98:
Absence of S9-mix: 0.028, 0.088, 0.28, 0.86, 2.7 and 8.4 μg/plate.
Presence of S9-mix: 0.28, 0.86, 2.7, 8.4, 26 and 82 μg/plate. - Vehicle / solvent:
- Ethanol.
- Untreated negative controls:
- yes
- Remarks:
- Ethanol
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: ICR-191; 2-aminoanthracene
- Details on test system and experimental conditions:
- All incubations were carried out in a controlled environment at a temperature of 37.0 ± 1.0°C.
- Evaluation criteria:
- A Salmonella typhimurium reverse mutation assay and/or Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria:
a) The vehicle control and positive control plates from each tester strain (with or without S9-mix) must exhibit a characteristic number of revertant colonies when compared against relevant historical control data generated at Charles River Den Bosch.
b) The selected dose-range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extend to 5 mg/plate.
c) No more than 5% of the plates are lost through contamination or some other unforeseen event. If the results are considered invalid due to contamination, the experiment will be repeated.
A test item is considered negative (not mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537 or TA98 is not greater than three (3) times the concurrent control.
b) The negative response should be reproducible in at least one follow up experiment.
A test item is considered positive (mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is greater than two (2) times the concurrent control, or the total number of revertants in tester strains TA1535, TA1537 or TA98 is greater than three (3) times the concurrent control.
b) In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one follow up experiment. - Statistics:
- Not applicable.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- In conclusion, the substance is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
- Executive summary:
In the in vitro genotoxicity study (Ames test) the substance was tested for mutagenicity in Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100, and in Escherichia coli strain WP2 uvrA. A dose-range finding test was conducted using eight concentrations of the substance (1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate) were tested in triplicate. The highest concentration of the substance used in the first mutation assay was the level at which the substance inhibited bacterial growth. This was followed with the first experiment (Direct Plate Assay) employing concentrations of 0.18, 0.55, 1.7, 5.4, 17 and 52 μg/plate. The second experiment (Pre-Incubation Assay) used concentrations of 0.17, 0.55, 1.7, 5.4, 17, 52 and 164 µg/plate with TA100 and WP2uvrA. Based on the results of this test the following concentrations were used for TA1535, TA1537 and TA98:
in the absence of S9-mix: 0.028, 0.088, 0.28, 0.86, 2.7 and 8.4 μg/plate and in the presence of S9-mix: 0.28, 0.86, 2.7, 8.4, 26 and 82 μg/plate. No evidence of mutagenic activity was seen at any concentration of the substance in either mutation test. It was concluded that the substance showed no evidence of mutagenic activity in these bacterial systems under the test conditions employed.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03 November 2017 - 18 February 2018.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- Adopted 29 July 2016
- Deviations:
- yes
- Remarks:
- In cytogenetic assay 2A not enough cells were scored in one of the duplicates of the dose level of 250 µg/mL. The duplicate culture showed similar results. Therefore this deviation was considered not to have affected the study integrity.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: A0378021
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: In refrigerator (2-8°C)
- Stability under test conditions: 31 October 2019 (retest date)
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was soluble in ethanol. - Species / strain / cell type:
- lymphocytes: peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- Blood was collected from healthy adult, non-smoking volunteers (approximately 18 to 35 years of age). The Average Generation Time (AGT) of the cells and the age of the donor at the time the AGT was determined.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat S9 homogenate was obtained from male Sprague Dawley rats that have been dosed orally with a suspension of phenobarbital and ß-naphthoflavone.
- Test concentrations with justification for top dose:
- The highest tested concentration was determined by the solubility of 3- Chloroperoxybenzoic Acid in the culture medium.
In the dose-range finding study, blood cultures were treated with 31.3, 62.5, 125, 250, 500 and 1000 µg 3- Chloroperoxybenzoic Acid/mL culture medium with and without S9-mix.
Based on the results of the dose-range finding test the following dose levels were selected for the cytogenetic assay:
With and without S9-mix: 25, 50, 100, 150, 200, 250, 300 and 350 µg/mL culture medium (3 h exposure time, 24 h fixation time)
The following dose levels were selected for the second cytogenetic assay:
Without S9-mix: 25, 75, 100, 150, 200, 300, 400 and 500 µg/mL culture medium (24 h and 48 h exposure time, 24 h and 48 h fixation time) - Vehicle / solvent:
- Ethanol.
- Untreated negative controls:
- yes
- Remarks:
- Ethanol
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Evaluation criteria:
- A chromosome aberration test is considered acceptable if it meets the following criteria:
a) The concurrent negative control data are considered acceptable when they are within the 95% control limits of the distribution of the historical negative control database.
b) The concurrent positive controls should induce responses that are compatible with those generated in the historical positive control database.
c) The positive control item induces a statistically significant increase in the number of cells with chromosome aberrations. The positive control data will be analyzed by the Fisher’s exact test (one-sided, p < 0.05).
A test item is considered positive (clastogenic) in the chromosome aberration test if:
a) At least one of the test concentrations exhibits a statistically significant (Fisher’s exact test, one-sided, p < 0.05) increase compared with the concurrent negative control.
b) The increase is dose related when evaluated with a trend test.
c) Any of the results are outside the 95% control limits of the historical control data range.
A test item is considered negative (not clastogenic) in the chromosome aberration test if:
a) None of the test concentrations exhibits a statistically significant (Fisher’s exact test, one-sided, p < 0.05) increase compared with the concurrent negative control.
b) There is no concentration-related increase when evaluated with a trend test.
c) All results are inside the 95% control limits of the negative historical control data range. - Statistics:
- Graphpad Prism version 4.03 (Graphpad Software, San Diego, USA) was used for statistical analysis of the data.
- Key result
- Species / strain:
- mammalian cell line, other: lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: The test item did not induce any statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in the absence and presence of S9-mix, in either of the two independently performed experiments.
- Conclusions:
- Both in the absence and presence of S9-mix the substance did not induce any statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in two independent experiments.
- Executive summary:
The potential for the substance to induce structural chromosome aberrations in cultured human lymphocytes, either in the presence or absence of a metabolic activation system (S9-mix) was evaluated in an in vitro study. The possible clastogenicity of the test item was tested in two independent experiments. In the first cytogenetic assay, the substance was tested up to 300 and 200 µg/mL for a 3 h exposure time with a 24 h fixation time in the absence and presence of 1.8% (v/v) S9-fraction, respectively. Appropriate toxicity was reached at these dose levels. In the second cytogenetic assay, the substance was tested up to 200 µg/mL for a 24 h continuous exposure time with a 24 h fixation time and up to 100 µg/mL for a 48 h continuous exposure time with a 48 h fixation time in the absence of S9-mix. Appropriate toxicity was reached at these dose levels. The substance did not induce any statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in the absence and presence of S9-mix, in either of the two independently performed experiments. In conclusion, the substance is not clastogenic in human lymphocytes under the experimental conditions employed in this study.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 March 2018 - 14 May 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- 29 July 2016
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Specific details on test material used for the study:
- Batch: A0378021
Purity/Composition: 98.8% of 3- Chloroperoxybenzoic acid (72%) balanced with 3- chlorobenzoic acid (8.8%) and water (18%)
Test item storage: In refrigerator (2-8°C)
Stable under storage conditions until: 31 October 2019 (retest date) - Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- L5178Y/TK+/--3.7.2C mouse lymphoma cells.
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes (S9 homogenate) were obtained from male Sprague Dawley rats that have been dosed orally with a suspension of phenobarbital (80 mg/kg body weight) and ß-naphthoflavone (100 mg/kg body weight).
- Test concentrations with justification for top dose:
- Since the test item was poorly soluble in the exposure medium, the highest tested concentration was 1000 μg/mL (range 63 to 1000 µg/mL) exposure medium.
First Mutagenicity Test: Without and with S9-mix: 1, 5, 10, 50, 100, 300, 600, 700, 800, 900 and 1000 μg/mL exposure medium.
Too many dose levels showed severe cytotoxicity, therefore this experiment was repeated (experiment 1A): the following dose-ranges were selected:
Without S9-mix: 10, 20, 40, 50, 100, 150, 200, 250, 300, 600, 700, 800, 900 and 1000 μg/mL exposure medium.
With S9-mix: 10, 20, 30, 40, 50, 75, 100, 200, 300, 600, 700, 800, 900 and 1000 μg/mL exposure medium.
Second Mutagenicity Test: 3.1, 6.3, 12.5, 25, 50, 100, 200, 300, 400, 450 and 500 µg/mL exposure medium (based on the results of the dose-range finding test and experiment 1) - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- yes
- Remarks:
- Ethanol
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Rationale for test conditions:
- Recommended test conditions in international guidelines (e.g. OECD).
- Evaluation criteria:
- Any increase of the mutation frequency should be evaluated for its biological relevance including comparison of the results with the historical control data range.
The global evaluation factor (GEF) has been defined by the IWGT as the mean of the negative/solvent MF distribution plus one standard deviation. For the micro well version of the assay the GEF is 126.
A substance is considered positive (mutagenic) in the mutation assay if it induces a MF of more than MF(controls) + 126 in a dose-dependent manner. An observed increase should be biologically relevant and will be compared with the historical control data range.
A substance is considered equivocal (questionable) in the mutation assay if no clear conclusion for positive or negative result can be made after an additional confirmation study.
A substance is considered negative (not mutagenic) in the mutation assay if: none of the tested concentrations reaches a mutation frequency of MF(controls) + 126. - Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In the dose-range finding test, L5178Y mouse lymphoma cells were treated with a substance concentration range of 63 to 1000 µg/mL in the absence of S9-mix with 3 and 24 hour treatment periods and in the presence of S9-mix with a 3 hour treatment period.
3 hours of treatment: In the absence and presence of S9-mix, the relative suspension growth was 2 and 8% at the substance concentration of 1000 μg/mL, respectively, compared to the relative suspension growth of the solvent control.
24 hours of treatment: The relative suspension growth was 8% at the substance concentration of 500 μg/mL compared to the relative suspension growth of the solvent control. No cell survival was observed at the substance concentration of 1000 μg/mL. - Conclusions:
- The substance is not mutagenic in the TK mutation test system under the experimental conditions described in this study.
- Executive summary:
The mutagenic potential of the substance was evaluated by testing its ability to induce forward mutations at the thymidine kinase (TK) locus in L5178Y mouse lymphoma cells, either in the absence or presence of a metabolic system (S9-mix). The test was performed in the absence of S9-mix with 3 and 24 hour treatment periods and in the presence of S9-mix with a 3 hour treatment period based on the most recent OECD guideline. In the first experiment, the substance was tested up to the concentration of 1000 µg/mL in the absence and presence S9-mix. The incubation time was 3 hours. Relative total growth (RTG) was reduced to 21 and 30% in the absence and presence of S9-mix, respectively. The substance precipitated in the culture medium at this dose level. In the second experiment, the substance was tested up to the concentration of 400 µg/mL in the absence of S9-mix. The incubation time was 24 hours. The RTG was reduced to 11%. The substance did not precipitate in the culture medium at this dose level. The mutation frequency found in the solvent control cultures was within the acceptability criteria of this assay and within the 95% control limits of the distribution of the historical negative control database. In the absence of S9-mix, the substance did not induce a biologically relevant increase in the mutation frequency in the first experiment, i.e. none of the tested concentrations reached a mutation frequency of MF(controls)+ 126. This result was confirmed in an independent experiment with modification in the duration of treatment. In the presence of S9-mix, the substance did not induce a biologically relevant increase in the mutation frequency, i.e. none of the tested concentrations reached a mutation frequency of MF(controls)+ 126. the study concluded that the substance is not mutagenic in the TK mutation test system under the experimental conditions described in this study.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 March 2018 - 19 June 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- adopted 29 July 2016
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Test concentrations with justification for top dose:
- First Mutagenicity Test:
Without S9-mix: 10, 20, 40, 50, 100, 150, 200, 250, 300, 600, 700, 800, 900 and 1000 μg/mL exposure medium.
With S9-mix: 10, 20, 40, 50, 100, 300, 800 and 1000 μg/mL exposure medium.
Second Mutagenicity Test
3.1, 6.3, 12.5, 25, 50, 100, 200, 300, 400, 450 and 500 µg/mL exposure medium. - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The substance is not mutagenic in the TK mutation test system
- Executive summary:
The mutagenic potential of the substance was evaluated by testing its ability to induce forward mutations at the thymidine kinase (TK) locus in L5178Y mouse lymphoma cells, either in the absence or presence of a metabolic system (S9-mix). The vehicle of the test item was ethanol. In the first experiment, the substance was tested up to the concentration of 1000 µg/mL in the absence and presence S9-mix. The incubation time was 3 hours. Relative total growth (RTG) was reduced to 21 and 6% in the absence and presence of S9-mix, respectively. The substance precipitated in the culture medium at this dose level. In the second experiment, the substance was tested up to the concentration of 400 µg/mL in the absence of S9-mix. The incubation time was 24 hours. The RTG was reduced to 11%. The substance did not precipitate in the culture medium at this dose level. The mutation frequency found in the solvent control cultures was within the acceptability criteria of this assay and within the 95% control limits of the distribution of the historical negative control database. Positive control chemicals, methyl methanesulfonate and cyclophosphamide, both produced significant increases in the mutation frequency. In addition, the mutation frequency found in the positive control cultures was within the 95% control limits of the distribution of the historical positive control database. It was therefore concluded that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly. In the absence of S9-mix, the substance did not induce a biologically relevant increase in the mutation frequency in the first experiment, i.e. none of the tested concentrations reached a mutation frequency of MF(controls)+ 126. This result was confirmed in an independent experiment with modification in the duration of treatment. In the presence of S9-mix, the substance did not induce a biologically relevant increase in the mutation frequency, i.e. none of the tested concentrations reached a mutation frequency of MF(controls)+ 126. In conclusion, the substance is not mutagenic in the mouse lymphoma L5178Y test system under the experimental conditions described in this study.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the findings of reliable in vitro genotoxicity studies conducted on the substance, classification of the substance is not justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.